Regulatory and procedural guideline: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure (updated)-2023/7/31

国家药监局综合司关于同意广东省药品检验所调整生物制品批签发证明文件授权签字人的复函 药监综药管函〔2024〕91号-2024/3/1

Page: Availability of medicines before and during crises-2025/2/3

国家药监局关于发布医疗器械临床试验项目检查要点及判定原则的公告（2025年第22号）-2025/3/12

Document: Questions & answers - Practical arrangements on the companion diagnostics consultation procedure to the European Medicines Agency by notified bodies - tracked changes-2025/4/11

Document: Timetable: Type II variation and worksharing application alternative monthly assessment-2025/5/23

Document: ICH E20 guideline on adaptive designs for clinical trials - Step 2b-2025/6/30

Document: List of EU Medicines Regulatory Agency Organisation with single and multiple LOC IDs for Product Management Services (PMS) data enrichment - Chapter 2 Annex III-2025/7/31

Document: Substances considered as not falling within the scope of Regulation (EC) No. 470/2009, with regard to residues of veterinary medicinal products in foodstuffs of animal origin-2025/9/19

Quality Management System Information for Certain Premarket Submission Reviews Draft Guidance for Industry and Food and Drug Administration Staff-2025/10/27